MiddleGround Capital has completed its voluntary public takeover offer of Stemmer Imaging, a provider of machine and artificial vision technology, for a total equity value of around €312 million.

Programmed cell death-1, or PD-1, has become a headline-grabbing molecule best known for its role in cancer immunotherapies ...

Baron Funds, an investment management company, released its “Baron Discovery Fund” third quarter 2024 investor letter. A copy ...

These CEOs partnered with them anyway. Every time Greg Salario chats with an entrepreneur who’s thinking about striking a ...